Show Parent

September

A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma Wenzel S.E. Eur Respir J 2003; 22: 397-398
Photodynamic therapy: where do we go from here? Moro-Sibilot D., Brambilla C. Eur Respir J 2003; 22: 399-400
The black box of lung redox Hunt J. Eur Respir J 2003; 22: 401-402
Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8 Bull T.M., Cool C.D., Serls A.E., Rai P.R., Parr J., Neid J.M., Geraci M.W., Campbell T.B., Voelkel N.F., Badesch D.B. Eur Respir J 2003; 22: 403-407
Expression of the serotonin 1b receptor in experimental pulmonary hypertension Rondelet B., Van Beneden R., Kerbaul F., Motte S., Fesler P., McEntee K., Brimioulle S., Ketelslegers J-M., Naeije R. Eur Respir J 2003; 22: 408-412
Chronic cough and phlegm in young adults Cerveri I., Accordini S., Corsico A., Zoia M.C., Carrozzi L., Cazzoletti L., Beccaria M., Marinoni A., Viegi G., de Marco R. Eur Respir J 2003; 22: 413-417
Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients Castaldo G., Tomaiuolo R., Sanduzzi A., Ponticiello A., Marchetiello I., Salvatore F. Eur Respir J 2003; 22: 418-421
Diagnostic implications of telomerase activity in pleural effusions Dikmen G., Dikmen E., Kara M., Sahin E., Dogan P., Ozdemir N. Eur Respir J 2003; 22: 422-426
Cathepsins in bleomycin-induced lung injury in rat Koslowski R., Knoch K., Kuhlisch E., Seidel D., Kasper M. Eur Respir J 2003; 22: 427-435
Bleomycin induces cellular senescence in alveolar epithelial cells Aoshiba K., Tsuji T., Nagai A. Eur Respir J 2003; 22: 436-443
Do GOLD stages of COPD severity really correspond to differences in health status? Antonelli-Incalzi R., Imperiale C., Bellia V., Catalano F., Scichilone N., Pistelli R., Rengo F., the SaRA investig... Eur Respir J 2003; 22: 444-449
Upregulation of MCAM in primary bronchial epithelial cells from patients with COPD Schulz C., Petrig V., Wolf K., Kratzel K., Kohler M., Becker B., Pfeifer M. Eur Respir J 2003; 22: 450-456
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Ichinose M., Sugiura H., Yamagata S., Koarai A., Tomaki M., Ogawa H., Komaki Y., Barnes P.J., Shirato K., Hattori T. Eur Respir J 2003; 22: 457-461
The occupational burden of chronic obstructive pulmonary disease Trupin L., Earnest G., San Pedro M., Balmes J.R., Eisner M.D., Yelin E., Katz P.P., Blanc P.D. Eur Respir J 2003; 22: 462-469
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma The ENFUMOSA Study Group Eur Respir J 2003; 22: 470-477
Systematic assessment of difficult-to-treat asthma Robinson D.S., Campbell D.A., Durham S.R., Pfeffer J., Barnes P.J., Chung K.F. Eur Respir J 2003; 22: 478-483
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Duncan C.J.A., Lawrie A., Blaylock M.G., Douglas J.G., Walsh G.M. Eur Respir J 2003; 22: 484-490
Evidence of mast cell activation and leukotriene release after mannitol inhalation Brannan J.D., Gulliksson M., Anderson S.D., Chew N., Kumlin M. Eur Respir J 2003; 22: 491-496
Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL Reinhardt N., Chen C.I.U., Loppow D., Schink T., Kleinau I., Jorres R.A., Wahn U., Magnussen H., Paul K.P. Eur Respir J 2003; 22: 497-502
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Jones A.M., Martin L., Bright-Thomas R.J., Dodd M.E., McDowell A, Moffitt K.L., Elborn J.S., Webb A.K. Eur Respir J 2003; 22: 503-506
Respiratory symptoms in children and exposure to pesticides Salameh P.R., Baldi I., Brochard P., Raherison C., Abi Saleh B., Salamon R. Eur Respir J 2003; 22: 507-512
Incidence of probable occupational asthma and changes in airway calibre and responsiveness in apprentice welders El-Zein M., Malo J-L., Infante-Rivard C., Gautrin D. Eur Respir J 2003; 22: 513-518
Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades Dumortier P., Thimpont J., de Maertelaer V., De Vuyst P. Eur Respir J 2003; 22: 519-524
Treatment of chronic respiratory failure in kyphoscoliosis: oxygen or ventilation? Buyse B., Meersseman W., Demedts M. Eur Respir J 2003; 22: 525-528
Spirometric reference values in a large Middle Eastern population Golshan M., Nematbakhsh M., Amra B., Crapo R.O. Eur Respir J 2003; 22: 529-534
Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Moghissi K., Dixon K. Eur Respir J 2003; 22: 535-541
Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions Currie B.J. Eur Respir J 2003; 22: 542-550
Controversies in epidemiology of occupational asthma Gautrin D., Newman-Taylor A.J., Nordman H., Malo J-L. Eur Respir J 2003; 22: 551-559
Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation Abramowicz M.J., Van Haecke P., Demedts M., Delcroix M. Eur Respir J 2003; 22: 560-562
A 26-yr-old male with recurrent respiratory infections Genta P.R., Costa M.V.O., Stelmach R., Cukier A. Eur Respir J 2003; 22: 564-567
Distribution of therapeutic response in asthma control Braunstein G.L. Eur Respir J 2003; 22: 568
From the Authors Reiss T.F., Edelman J.M., Heyse J.F. Eur Respir J 2003; 22: 568-569
Carbon monoxide transfer coefficient (transfer factor/alveolar volume) in females versus males. J.M.B. Hughes, N.B. Pride. Eur Respir J 2003; 22: 570